Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice.

Holowacz, S; Blondeau, C; Guinobert, I; Guilbot, A; Hidalgo, S; Bisson, J F

Holowacz, S; Blondeau, C; Guinobert, I; Guilbot, A; Hidalgo, S; Bisson, J F.

Affiliation

Holowacz S; 1 Groupe PiLeJe, 37 Quai de Grenelle, 75015 Paris Cedex 15, France.
Blondeau C; 1 Groupe PiLeJe, 37 Quai de Grenelle, 75015 Paris Cedex 15, France.
Guinobert I; 1 Groupe PiLeJe, 37 Quai de Grenelle, 75015 Paris Cedex 15, France.
Guilbot A; 1 Groupe PiLeJe, 37 Quai de Grenelle, 75015 Paris Cedex 15, France.
Hidalgo S; 2 Etap-Lab, 13 Rue du Bois de la Champelle, 54500 VandÅuvre-lès-Nancy, France.
Bisson JF; 2 Etap-Lab, 13 Rue du Bois de la Champelle, 54500 VandÅuvre-lès-Nancy, France.

Benef Microbes ; 9(2): 299-309, 2018 Feb 27.

Article in En | MEDLINE | ID: mdl-29409331

Subject(s)

Dermatitis, Atopic/drug therapy; Lacticaseibacillus rhamnosus/physiology; Ligilactobacillus salivarius/physiology; Probiotics/therapeutic use; Animals; Bifidobacterium/physiology; Cytokines/blood; Dermatitis, Atopic/chemically induced; Dermatitis, Atopic/pathology; Dermatitis, Atopic/prevention & control; Disease Models, Animal; Female; Immunomodulation; Mice; Mice, Hairless; Probiotics/administration & dosage; Tetradecanoylphorbol Acetate

Key words

atopic dermatitis; cytokine; prevention; probiotics; skin inflammation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Probiotics / Dermatitis, Atopic / Lacticaseibacillus rhamnosus / Ligilactobacillus salivarius Type of study: Prognostic_studies Limits: Animals Language: En Journal: Benef Microbes Year: 2018 Document type: Article Affiliation country: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google